News
NSPR
0.8000
+2.56%
0.0200
InspireMD Q3 2026 Earnings Preview
Seeking Alpha · 15h ago
908 Devices Inc. (MASS) Reports Q3 Loss, Tops Revenue Estimates
NASDAQ · 1d ago
Weekly Report: what happened at NSPR last week (1102-1106)?
Weekly Report · 2d ago
TransMedics (TMDX) Q3 Earnings and Revenues Surpass Estimates
NASDAQ · 6d ago
LivaNova (LIVN) Surpasses Q3 Earnings and Revenue Estimates
NASDAQ · 11/04 11:20
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 11/02 17:05
Weekly Report: what happened at NSPR last week (1026-1030)?
Weekly Report · 11/02 09:30
Weekly Report: what happened at NSPR last week (1019-1023)?
Weekly Report · 10/26 09:30
InspireMD management to meet virtually with Lake Street
TipRanks · 10/20 15:05
Weekly Report: what happened at NSPR last week (1012-1016)?
Weekly Report · 10/19 09:30
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 10/16 12:05
Weekly Report: what happened at NSPR last week (1005-1009)?
Weekly Report · 10/12 09:32
Weekly Report: what happened at NSPR last week (0928-1002)?
Weekly Report · 10/05 09:32
Weekly Report: what happened at NSPR last week (0921-0925)?
Weekly Report · 09/28 09:30
InspireMD Amends Warrants to Support CGuard Prime Launch
TipRanks · 09/21 13:28
Weekly Report: what happened at NSPR last week (0914-0918)?
Weekly Report · 09/21 09:30
Weekly Report: what happened at NSPR last week (0907-0911)?
Weekly Report · 09/14 09:32
Weekly Report: what happened at NSPR last week (0831-0904)?
Weekly Report · 09/07 09:29
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 09/02 12:07
Why Dell Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Benzinga · 09/02 08:57
More
Webull provides a variety of real-time NSPR stock news. You can receive the latest news about Inspiremd through multiple platforms. This information may help you make smarter investment decisions.
About NSPR
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). It markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. It is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.